Interaction Guide · Research summary

Can I take Passiflora Incarnata with Temazepam?

Review Passiflora Incarnata with Temazepam: possible adverse effects, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

Review passionflower before using it with temazepam. The exact combination’s sedation risk is not established, and short studies of passionflower alone do not settle the question.

What this answer covers

Oral Passiflora incarnata aerial-part preparations, not another species or every extract.

Supplement or preparation
Passiflora incarnata
Medication ingredient
temazepam

Read both parts of the guidance

The passionflower monograph describes possible driving impairment and traditional sleep-aid use. It also lists no reported interactions. Neither statement proves a temazepam interaction.

Short trials provide limited reassurance

Two small perioperative studies did not find greater sedation or psychomotor impairment with their passionflower products. They did not test ongoing co-use with temazepam.

Check the actual sleep product

Bring its species, plant part and other ingredients. No validated spacing rule resolves the missing combination evidence.

Protect your alertness

Temazepam can impair coordination and alertness. Avoid driving when affected. Seek urgent help for severe difficulty waking or breathing, and tell the prescriber about all other sedating medicines and alcohol.

Evidence and practical considerations

Side effects & toxicity

A cautious product review is reasonable, but exact additive sedation remains insufficiently established.

Exact scope
Oral Passiflora incarnata aerial-part preparations, not another species or every extract. with Exact oral temazepam; no blanket benzodiazepine metabolic or route transfer.
Medication form and route
oral; other cannabis routes only if explicitly discussed
Timing or duration
Exact duration and dose depend on source; single-dose and chronic use are distinguished.

What remains uncertain

  • Monograph lists no reported interactions; perioperative studies did not find added sedation with their preparations. No routine temazepam co-use study.

Factors that may matter: preparation and plant part; dose; other medicines; baseline alertness; clinical indication.

Research conclusion: insufficient evidence · Evidence assessment: low

Read the supporting source summaries

Source 1: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: Patients prescribed oral temazepam.

CNS depression, impaired coordination and alertness can occur; concomitant CNS depressants require caution. Dependence and withdrawal risks require individualized tapering rather than abrupt cessation. Metabolized primarily through conjugation with no active metabolites; not an alprazolam CYP3A profile. Complex sleep behaviors can occur and CNS depressants may increase their risk.

How this applies: Exact RxNorm ingredient and oral formulation confirmed in original label; use exact indication and metabolic boundaries.

Does not quantify the requested botanical interaction risks, prove every herb is sedating, or establish a protective supplement interval.

Source 2: official guidance

ema.europa.eu · Source check Sep 10, 2026

Population: People considering the specified supplement.

Traditional sleep-aid use; may impair driving. Section 4.5 lists no reported interactions.

How this applies: Preparation-specific context; not a directly measured temazepam interaction.

Traditional-use monograph, not a temazepam trial. No reported interaction is not proof of safety.

Source 3: randomized placebo-controlled trial

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: 60 adults undergoing ambulatory surgery.

Anxiety decreased, but sedation and psychomotor recovery were similar between groups.

How this applies: Preparation-specific context; not a directly measured temazepam interaction.

Short perioperative exposure to one product, no temazepam; does not establish chronic combination safety.

Source 4: randomized placebo-controlled trial

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: 60 adults aged 25-55 undergoing spinal anesthesia.

No significant group differences in sedation, psychomotor function, hemodynamics or side effects.

How this applies: Preparation-specific context; not a directly measured temazepam interaction.

Selected perioperative population, no temazepam; not proof that all preparations lack impairment.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Article prepared
Current exact claims adjudicated against captured originals and explicit comparator/co-use boundaries.
Research summary published

Article revision: ee85d0503f397f46

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.